Immunology Market Size to Grow USD 102790 Million by 2029 at a CAGR of 6.5% | Valuates Reports
BANGALORE, India, Dec. 11, 2023 /PRNewswire/ -- Immunology Market is Segmented by Type (Immuno Boosters, Immunosuppressants), by Application (Autoimmune Diseases, Oncology, Organ Transplantation): Global Opportunity Analysis and Industry Forecast, 2023-2029. It is Published in Valuates Reports Under the Category of Pharmaceuticals & Biotech.
The global Immunology Market is projected to grow from USD 70450 Million in 2023 to USD 102790 Million by 2029, at a Compound Annual Growth Rate (CAGR) of 6.5% during the forecast period.
Claim Your Free Sample Now:
https://reports.valuates.com/request/sample/QYRE-Auto-20H6044/Global_Immunology
Major Factors driving the growth of Immunology Market:
A number of factors are coming together to drive the strong growth of the immunology market. The need for immunological interventions is growing as a result of advancements in immunotherapy, particularly in adoptive cell therapies and monoclonal antibodies, which are revolutionizing the way diseases are treated. In the field of immunology, there is a growing market for pharmaceuticals, biologics, and diagnostics due to the rising prevalence of chronic diseases and the growing applications in the management of infectious diseases.
Own It Today – Buy Now!
https://reports.valuates.com/api/directpaytoken?rcode=QYRE-Auto-20H6044&lic=single-user
TRENDS INFLUENCING THE GROWTH OF IMMUNOLOGY MARKET:
The rise in the market for immunology is largely due to the rising incidence of chronic illnesses like cancer, allergies, and autoimmune disorders. The need for immunological interventions and therapies is growing as these conditions spread throughout the world, which is driving up demand for pharmaceuticals, biologics, and diagnostic tools in the immunology sector. An essential part of treating infectious diseases is immunology. The immunology market is expanding as a result of the continuous problems brought on by newly discovered infectious agents as well as the requirement for efficient vaccinations and antiviral treatments. This market segment's growth is mostly due to the development of innovative vaccines and immunotherapies to treat infectious diseases.
The identification and development of biomarkers for immunological disorders has been accelerated by the era of personalized medicine. The importance of customizing treatments based on patients' unique immune profiles is rising as our understanding of individualized immune responses deepens. Research, development, and commercialization activities are driven by this individualized approach, which supports the immunology market's overall growth.
Innovation in immunology is being promoted by alliances and collaborations between biotechnology companies, research institutes, and pharmaceutical companies. Together, research and development efforts uncover new therapeutic targets, create cutting-edge medications, and expand our understanding of immunology. The immunology market is expanding and becoming more diverse as a result of these joint efforts.
The market is growing because of favorable regulatory frameworks and quick approval procedures for immunological treatments. The proactive approach taken by regulatory agencies to expedite the development and approval of immunological products results in their timely introduction into the market, thereby meeting unfulfilled medical needs and offering patients novel therapeutic options.
Awareness campaigns and educational initiatives that improve public and healthcare professionals' understanding of immune-related disorders and available treatments have an impact on the growth of the immunology market. Raising awareness promotes early identification, diagnosis, and intervention, which in turn fuels demand for immunological goods and services and supports the expansion of the market.
Unlock Insights: View Full Report Now!
https://reports.valuates.com/market-reports/QYRE-Auto-20H6044/global-immunology
IMMUNOLOGY MARKET SHARE ANALYSIS
Due to its strong regulatory framework, high investments in research and development, and established healthcare infrastructure, North America has a sizable market share in immunology. The region's dominance is attributed to a proactive approach to immunotherapy as well as the prevalence of cancer and autoimmune diseases. The immunology market in the US and Canada is expanding due in part to the presence of significant market players and a strong focus on personalized medicine.
Purchase Chapters:
https://reports.valuates.com/request/chaptercost/QYRE-Auto-20H6044/Global_Immunology
Key Players:
- AbbVie
- Amgen Inc
- F.Hoffmann-La Roche
- Johnson & Johnson
- Bionor Pharma
- Celgene
- Cellectar Biosciences
- eFFECTOR Therapeutics
Purchase Regional Data:
https://reports.valuates.com/request/regional/QYRE-Auto-20H6044/Global_Immunology
SUBSCRIPTION
We have introduced a tailor-made subscription for our customers. Please leave a note in the Comment Section to know about our subscription plans.
DISCOVER MORE INSIGHTS: EXPLORE SIMILAR REPORTS!
- Computational Immunology Market
- Flow Cytometry in Oncology and Immunology Market
- Infectious Immunology market size is expected to reach USD 37790 million by 2029, growing at a CAGR of 7.9% from 2023 to 2029.
- Immunology Testing Services Market
- Next-Generation Immunology Drugs Market
- Ulcerative Colitis Immunology Drugs Market
- Homeopathy market was valued at USD 920.2 million in 2022 and is anticipated to reach USD 1388.8 million by 2029, witnessing a CAGR of 7.1% during the forecast period 2023-2029.
- Cancer Immunotherapy market size is projected to reach USD 135140 million by 2028, from USD 75950 million in 2021, at a CAGR of 8.1% during 2022-2028.
- Infectious Disease Diagnostics market size is projected to reach USD 4776.2 Million by 2027, from USD 3644 Million in 2020, at a CAGR of 4.3%.
- The global cancer diagnostics market size was valued at USD 168,600.04 Million in 2020, and is projected to reach USD 280,590.21 Million by 2028, registering a CAGR of 6.9% from 2021 to 2028.
- Cancer Vaccines market size is estimated to be worth USD 4755.6 million in 2021 and is forecast to a readjusted size of USD 12220 million by 2028 with a CAGR of 14.3%.
- Therapeutic Cancer Vaccines Market
- Antibody Purification Services Market
- Plasma Fractionation market size is expected to reach USD 47210 million by 2029, growing at a CAGR of 7.6% from 2023 to 2029.
- Natural Immune Booster Market
- Functional Additives for Feed market is projected to reach USD 444.9 million in 2029, increasing from USD 301 million in 2022, with the CAGR of 5.7% during the period of 2023 to 2029.
- Immune-Mediated Inflammatory Diseases Treatment
- Immune Boosting Supplement market is projected to reach USD 61420 million in 2029, increasing from USD 38120 million in 2022, with the CAGR of 7.4% during the period of 2023 to 2029.
- Immune Support Vitamins and Supplements market is projected to reach USD 2515.2 million in 2029, increasing from USD 1453.8 million in 2022, with the CAGR of 8.1% during the period of 2023 to 2029.
- Immune Cell Therapy Drugs market is projected to reach USD 17140 million in 2029, increasing from USD 2456 million in 2022, with the CAGR of 32.2% during the period of 2023 to 2029.
- Immune Health Supplements market was valued at USD 43750 million in 2022 and is anticipated to reach USD 68340 million by 2029, witnessing a CAGR of 6.5% during the forecast period 2023-2029.
- Immune Cell Banking Service Market
- Digital Immune System Market
DISCOVER OUR VISION: VISIT ABOUT US!
Valuates offers in-depth market insights into various industries. Our extensive report repository is constantly updated to meet your changing industry analysis needs.
Our team of market analysts can help you select the best report covering your industry. We understand your niche region-specific requirements and that's why we offer customization of reports. With our customization in place, you can request for any particular information from a report that meets your market analysis needs.
To achieve a consistent view of the market, data is gathered from various primary and secondary sources, at each step, data triangulation methodologies are applied to reduce deviance and find a consistent view of the market. Each sample we share contains a detailed research methodology employed to generate the report. Please also reach our sales team to get the complete list of our data sources.
YOUR FEEDBACK MATTERS: REACH OUT TO US!
Valuates Reports
sales@valuates.com
For U.S. Toll-Free Call 1-(315)-215-3225
WhatsApp: +91-9945648335
Website: https://reports.valuates.com
Blog: https://valuatestrends.blogspot.com/
Pinterest: https://in.pinterest.com/valuatesreports/
Twitter: https://twitter.com/valuatesreports
Logo: https://mma.prnewswire.com/media/1082232/Valuates_Reports_Logo.jpg
Share this article